Loading...
•
Dec 31, 2019
InspireMD Q4 2019 Earnings Report
Reported a revenue increase driven by CGuard EPS sales, offset by a decrease in MGuard Prime EPS sales and increased operating expenses due to separation agreement payments.
Key Takeaways
InspireMD reported a 23.2% increase in revenue for Q4 2019, driven by a 31.4% increase in CGuard EPS sales. However, this was partially offset by a decrease in MGuard Prime EPS sales and an increase in operating expenses, resulting in a net loss of $2,557,000, or $0.57 per share.
Revenue increased by 23.2% to $1,013,000 compared to Q4 2018.
CGuard EPS sales increased by 31.4% to $921,000.
Net loss for the quarter was $2,557,000, or $0.57 per share.
Gross margin decreased to 25.6% from 27.6% in the same period in 2018.
Revenue by Segment
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...